A platform for phenotyping disease progression and associated longitudinal risk factors in large-scale EHRs, with application to incident diabetes complications in the UK Biobank

Kim DH, Jensen A, Jones K, Raghavan S, Phillips LS, Hung A, Sun YV, Li G, Reaven P, Zhou H, Zhou JJ. A platform for phenotyping disease progression and associated longitudinal risk factors in large-scale EHRs, with application to incident diabetes complications in the UK Biobank. JAMIA Open. 2023 Feb 9;6(1):ooad006. doi: 10.1093/jamiaopen/ooad006. PMID: 36789288; PMCID: PMC9912368.


Related Posts

Susan Ettner, PhD and Dennis J. Slamon, MD, PhD Elected to the National Academy of Medicine featured image